China Perfusion Systems Market Size & Outlook, 2023-2030
China perfusion systems market, 2018-2030 (US$M)
Related Markets
China perfusion systems market highlights
- The China perfusion systems market generated a revenue of USD 59.0 million in 2023 and is expected to reach USD 86.5 million by 2030.
- The China market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
- In terms of segment, cardiopulmonary perfusion system was the largest revenue generating application in 2023.
- Cardiopulmonary Perfusion System is the most lucrative application segment registering the fastest growth during the forecast period.
Perfusion systems market data book summary
| Market revenue in 2023 | USD 59.0 million |
| Market revenue in 2030 | USD 86.5 million |
| Growth rate | 5.6% (CAGR from 2023 to 2030) |
| Largest segment | Cardiopulmonary perfusion system |
| Fastest growing segment | Cardiopulmonary Perfusion System |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
| Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
Other key industry trends
- In terms of revenue, China accounted for 5.3% of the global perfusion systems market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan perfusion systems market is projected to lead the regional market in terms of revenue in 2030.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 20.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Perfusion Systems Market Scope
Perfusion Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China perfusion systems market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to perfusion systems market will help companies and investors design strategic landscapes.
Cardiopulmonary perfusion system was the largest segment with a revenue share of 45.93% in 2023. Horizon Databook has segmented the China perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
With the high unmet needs of the growing population, the perfusion systems market is expected to experience significant growth. In 2023, the National Bureau of Statistics of China reported that individuals aged 60 and above made up about 19.8% of the population in 2022.
Healthcare reforms in China are expected to further drive market expansion. For instance, LifeSeeds, part of the China Rural Health Initiative (CRHI), aims to improve healthcare access in underserved regions, creating opportunities for market players.
In addition, China, the second-largest medical device market globally, is seeing an increasing prevalence of COPD and cardiopulmonary diseases, further boosting market growth. For instance, according to the WHO, in November 2023, nearly 100 million people in China suffered from COPD, representing about 25% of global COPD cases.
Reasons to subscribe to China perfusion systems market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China perfusion systems market databook
-
Our clientele includes a mix of perfusion systems market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China perfusion systems market , including forecasts for subscribers. This country databook contains high-level insights into China perfusion systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China perfusion systems market size, by application, 2018-2030 (US$M)
China Perfusion Systems Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
